Hans Lennart Rudolf Wigzell, Director at Sarepta Therapeutics, Inc. (SRPT), sold 13,334 shares at $140.50 ($1.9M) on 2018-11-01, disclosed to the SEC on 2018-11-02.
Open-market sale of $1.9M SRPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $140.50 | 6,667 | $937K | 50.0% |
| 2 | $140.50 | 6,667 | $937K | 50.0% |
| Total | $140.50 avg | 13,334 | $1.9M | 100% |
| Filing → |
| SRPT | SELL | 2023-08-08 | $1.6M | — | Filing → |
| SRPT | SELL | 2021-03-10 | $835K | — | Filing → |
| SRPT | SELL | 2020-08-11 | $3.2M | — | Filing → |